And this is if I can complement the we see that the trajectory is robust our big international clients, in particular the bio ...

For more information about the TOTY Awards voting and selection process, visit ToyAwards.org.

Armed with new clinical trial results, Amgen is expanding studies of its KRAS inhibitor Lumakras in pancreatic cancer, as it tries to extend the label for the first-in-class drug beyond its current ...